146 related articles for article (PubMed ID: 16155756)
1. MAGE-1/Heat shock protein 70/MAGE-3 fusion protein vaccine in nanoemulsion enhances cellular and humoral immune responses to MAGE-1 or MAGE-3 in vivo.
Ge W; Sui YF; Wu DC; Sun YJ; Chen GS; Li ZS; Si SY; Hu PZ; Huang Y; Zhang XM
Cancer Immunol Immunother; 2006 Jul; 55(7):841-9. PubMed ID: 16155756
[No Abstract] [Full Text] [Related]
2. The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following peroral administration route.
Ge W; Li Y; Li ZS; Zhang SH; Sun YJ; Hu PZ; Wang XM; Huang Y; Si SY; Zhang XM; Sui YF
Cancer Immunol Immunother; 2009 Feb; 58(2):201-8. PubMed ID: 18523770
[TBL] [Abstract][Full Text] [Related]
3. A novel DNA vaccine constructed by heat shock protein 70 and melanoma antigen-encoding gene 3 against tumorigenesis.
Qu P; Ma JH; Zhang XM; Huang XJ; Yang XW; Yan-Fang S
Indian J Exp Biol; 2010 May; 48(5):436-43. PubMed ID: 20795360
[TBL] [Abstract][Full Text] [Related]
4. Heat shock protein 70/MAGE-3 fusion protein vaccine can enhance cellular and humoral immune responses to MAGE-3 in vivo.
Ma JH; Sui YF; Ye J; Huang YY; Li ZS; Chen GS; Qu P; Song HP; Zhang XM
Cancer Immunol Immunother; 2005 Sep; 54(9):907-14. PubMed ID: 15756604
[TBL] [Abstract][Full Text] [Related]
5. The antitumor immune responses induced by nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine following different administration routes.
Ge W; Hu PZ; Huang Y; Wang XM; Zhang XM; Sun YJ; Li ZS; Si SY; Sui YF
Oncol Rep; 2009 Oct; 22(4):915-20. PubMed ID: 19724873
[TBL] [Abstract][Full Text] [Related]
6. Fusion of Hsp70 to Mage-a1 enhances the potency of vaccine-specific immune responses.
Jiang J; Xie D; Zhang W; Xiao G; Wen J
J Transl Med; 2013 Dec; 11():300. PubMed ID: 24314011
[TBL] [Abstract][Full Text] [Related]
7. Heat shock protein 70 / MAGE-1 tumor vaccine can enhance the potency of MAGE-1-specific cellular immune responses in vivo.
Ye J; Chen GS; Song HP; Li ZS; Huang YY; Qu P; Sun YJ; Zhang XM; Sui YF
Cancer Immunol Immunother; 2004 Sep; 53(9):825-34. PubMed ID: 15127237
[TBL] [Abstract][Full Text] [Related]
8. [Anti-tumor immune responses of nanoemulsion-encapsulated MHS vaccine].
Ge W; Sun YJ; Li Y; Zhang SH; Zhang XM; Huang Y; Hu PZ; Sui YF
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 May; 24(5):457-60. PubMed ID: 18466701
[TBL] [Abstract][Full Text] [Related]
9. Preparation of a new combination nanoemulsion-encapsulated MAGE1-MAGE3-MAGEn/HSP70 vaccine and study of its immunotherapeutic effect.
Zhang X; Huang Y; Li X; Wang Y; Yuan Y; Li M
Pathol Res Pract; 2020 Jun; 216(6):152954. PubMed ID: 32321658
[TBL] [Abstract][Full Text] [Related]
10. Heat shock protein 70 fused to or complexed with hantavirus nucleocapsid protein significantly enhances specific humoral and cellular immune responses in C57BL/6 mice.
Li J; Li KN; Gao J; Cui JH; Liu YF; Yang SJ
Vaccine; 2008 Jun; 26(25):3175-87. PubMed ID: 18479786
[TBL] [Abstract][Full Text] [Related]
11. [Construction of human MAGE-3 DNA vaccine and its immune effects observed in vivo].
Liu XE; Sun XD; Wu JM
Sheng Wu Gong Cheng Xue Bao; 2004 Mar; 20(2):165-9. PubMed ID: 15969102
[TBL] [Abstract][Full Text] [Related]
12. A Mage3/Heat Shock Protein70 DNA vaccine induces both innate and adaptive immune responses for the antitumor activity.
Wang L; Rollins L; Gu Q; Chen SY; Huang XF
Vaccine; 2009 Dec; 28(2):561-70. PubMed ID: 19835823
[TBL] [Abstract][Full Text] [Related]
13. The treatment and prevention of mouse melanoma with an oral DNA vaccine carried by attenuated Salmonella typhimurium.
Zhu X; Cai J; Huang J; Jiang X; Ren D
J Immunother; 2010 Jun; 33(5):453-60. PubMed ID: 20463603
[TBL] [Abstract][Full Text] [Related]
14. The use of a rapid ELISPOT assay to analyze peptide-specific immune responses in carcinoma patients to peptide vs. recombinant poxvirus vaccines.
Arlen P; Tsang KY; Marshall JL; Chen A; Steinberg SM; Poole D; Hand PH; Schlom J; Hamilton JM
Cancer Immunol Immunother; 2000 Dec; 49(10):517-29. PubMed ID: 11129322
[TBL] [Abstract][Full Text] [Related]
15. Fusion proteins of Hsp70 with tumor-associated antigen acting as a potent tumor vaccine and the C-terminal peptide-binding domain of Hsp70 being essential in inducing antigen-independent anti-tumor response in vivo.
Zhang H; Huang W
Cell Stress Chaperones; 2006; 11(3):216-26. PubMed ID: 17009594
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal anti-MAGE-3 CTL responses in melanoma patients displaying tumor regression after vaccination with a recombinant canarypox virus.
Karanikas V; Lurquin C; Colau D; van Baren N; De Smet C; Lethé B; Connerotte T; Corbière V; Demoitié MA; Liénard D; Dréno B; Velu T; Boon T; Coulie PG
J Immunol; 2003 Nov; 171(9):4898-904. PubMed ID: 14568971
[TBL] [Abstract][Full Text] [Related]
17. Tomato lectin-modified nanoemulsion-encapsulated MAGE1-HSP70/SEA complex protein vaccine: Targeting intestinal M cells following peroral administration.
Long P; Zhang Q; Xue M; Cao G; Li C; Chen W; Jin F; Li Z; Li R; Wang X; Ge W
Biomed Pharmacother; 2019 Jul; 115():108886. PubMed ID: 31029887
[TBL] [Abstract][Full Text] [Related]
18. A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein.
Zhang Y; Chaux P; Stroobant V; Eggermont AM; Corthals J; Maillère B; Thielemans K; Marchand M; Boon T; Van Der Bruggen P
J Immunol; 2003 Jul; 171(1):219-25. PubMed ID: 12817001
[TBL] [Abstract][Full Text] [Related]
19. Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy.
Estin CD; Stevenson US; Plowman GD; Hu SL; Sridhar P; Hellström I; Brown JP; Hellström KE
Proc Natl Acad Sci U S A; 1988 Feb; 85(4):1052-6. PubMed ID: 3422478
[TBL] [Abstract][Full Text] [Related]
20. Cancer vaccines: single-epitope anti-idiotype vaccine versus multiple-epitope antigen vaccine.
Maruyama H; Zaloudik J; Li W; Sperlagh M; Koido T; Somasundaram R; Scheck S; Prewett M; Herlyn D
Cancer Immunol Immunother; 2000 Jun; 49(3):123-32. PubMed ID: 10881691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]